[Methotrexate in therapy of chronic inflammatory bowel diseases].
Schröder
O
O
Medizinische Klinik II, Johann Wolfgang Goethe-Universität, Frankfurt.
Stein
J
J
D003093:Colitis, Ulcerative / Q000188:drug therapy* / Q000473:pathology; D003424:Crohn Disease / Q000188:drug therapy* / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007413:Intestinal Mucosa / Q000187:drug effects / Q000473:pathology; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use*; D011241:Prednisone / Q000008:administration & dosage; D011446:Prospective Studies
D007166:Immunosuppressive Agents; D011241:Prednisone; D008727:Methotrexate